Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential diagnosis of serous papillary carcinoma of the gynaecological tract and basal breast carcinoma: an immunohistochemical approach.

Pathology - 1 Jan 2010

Armes Jane E, Bowlay Greg, Lourie Rohan, Venter Deon J, Price Gareth

Abstract excerpt

AIMS: There is a high frequency of serous gynaecological and basal breast cancers in patients with germline BRCA1 mutations. These patients often undergo prophylactic salpingo-oophorectomies, where small tumours may be identified in which morphological distinction between primary serous and metas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Cystadenocarcinoma, Serous
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genital Neoplasms, Female

Share to Keratin-5

Share to Keratin-6

Share to Receptors, Estrogen

Share to WT1 Proteins

Source

Identifiers

PMID: 20854071
DOI: 10.3109/00313025.2010.508793

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20854071-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential diagnosis of serous papillary carcinoma of the gynaecological tract and basal breast carcinoma: an immunohistochemical approach.PMID 20854071Read ↗

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors.Semantic proximity Read ↗

Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian Cancer.Semantic proximity Read ↗

Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.Semantic proximity Read ↗

Small cell cancers of the female genital tract: Molecular and clinical aspectsSemantic proximity Read ↗

CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas.Semantic proximity Read ↗

Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management.Semantic proximity Read ↗

Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma.Semantic proximity Read ↗

Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues.Semantic proximity Read ↗

The status of epidermal growth factor receptor in borderline ovarian tumours.Semantic proximity Read ↗

Female Adnexal Tumors of Probable Wolffian Origin (FATWO): A Case Series With Next-Generation Sequencing Mutation AnalysisSemantic proximity Read ↗

Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations.Semantic proximity Read ↗

A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.